Skip to content

Lifevantage Corporation LFVN Debt Issuance Proceeds

Debt Issuance Proceeds at other companies

USANA Health Sciences logo
USANA Health SciencesUSNA
$4M
NuSkin Enterprises logo
NuSkin EnterprisesNUS
$225M
Herbalife logo
HerbalifeHLF
$67M+3.1%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$11.62M+1,481%
Solesence, Inc. Common Stock logo
Solesence, Inc. Common StockSLSN
$4.3M
Biote Corp. logo
Biote Corp.BTMD
$7.5M+500%

Other financials

Income statement

See full
Revenue$43.7M-25.2%
Gross profit$34.5M-27.0%
Operating income$1.7M-58.6%
Net income$1.4M-60.7%
EPS (diluted)$0.11-57.7%

Balance sheet

See full
Cash & equivalents$12.5M-44.4%
Total debt$10.2M-17.4%
Total equity$33.3M-2.0%
Total assets$62.1M-19.6%

Cash flow

See full
Operating cash flow$5.0M+124%
CapEx$1.0M+205%
Free cash flow$4.0M+110%

Valuation

See full
Market cap$78.72M-51.4%
Enterprise value$76.45M-50.2%
P/E13.7×-2.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin78.1%-2.2pp
Operating margin3.4%-2.5pp
Net margin2.9%-1.2pp
FCF margin3.8%+1.1pp

Returns & leverage

See full
Return on equity17.1%-13.0pp
Debt / equity0.3×-0.1×
Current ratio+0.3×

Where this comes from

Reported directly by Lifevantage Corporation in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromLinesOfCredit.

The official record: Lifevantage Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifevantage Corporation's debt issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Lifevantage Corporation's debt issuance proceeds?
Lifevantage Corporation (LFVN) reported debt issuance proceeds of $0 in Q1 2025.
What does debt issuance proceeds mean?
Cash received from issuing bonds, notes, term loans, and other debt instruments in the capital markets or from bank lending.